| | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $172,490 ) |
| 2024 | 2024 | UNIVERSITY OF CALIFORNIA IRVINE | 160 ALDRICH HALL | IRVINE | CA | 92697 | ORANGE | USA | Cancer Treatment Research | 000 | 4 | 7/23/2024 | NON-COMPETING CONTINUATION | $172,490 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2023 ( Subtotal = $513,465 ) |
| 2023 | 2023 | UNIVERSITY OF CALIFORNIA, IRVINE | 160 ALDRICH HALL | IRVINE | CA | 92697 | ORANGE | USA | Cancer Treatment Research | 000 | 3 | 6/20/2023 | NON-COMPETING CONTINUATION | $503,195 |
| 2023 | 2023 | UNIVERSITY OF CALIFORNIA IRVINE | 160 ALDRICH HALL | IRVINE | CA | 92697 | ORANGE | USA | Cancer Treatment Research | 001 | 3 | 9/13/2023 | NON-COMPETING CONTINUATION | $10,270 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2022 ( Subtotal = $502,694 ) |
| 2022 | 2022 | UNIVERSITY OF CALIFORNIA, IRVINE | 141 INNOVATION DR STE 250 | IRVINE | CA | 92617 | ORANGE | USA | Cancer Treatment Research | 000 | 2 | 6/24/2022 | NON-COMPETING CONTINUATION | $502,694 |
|
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2021 ( Subtotal = $527,905 ) |
| 2021 | 2021 | UNIVERSITY OF CALIFORNIA, IRVINE | 141 INNOVATION DR STE 250 | IRVINE | CA | 92617 | ORANGE | USA | Cancer Treatment Research | 001 | 1 | 9/1/2021 | NEW | $0 |
| 2021 | 2021 | UNIVERSITY OF CALIFORNIA, IRVINE | 141 INNOVATION DR STE 250 | IRVINE | CA | 92617 | ORANGE | USA | Cancer Treatment Research | 000 | 1 | 5/21/2021 | NEW | $527,905 |
|
|